docetaxel oral/ritonavir (ModraDoc006/r) / Modra Pharma |
| Withdrawn | 1 | 0 | Europe | ModraDoc006/r, oral docetaxel formulation | Modra Pharmaceuticals | Solid Tumor, Adult | 04/18 | 06/18 | | |
NCT03147378: Food Effect Study of ModraDoc006 in Combination With Ritonavir |
|
|
| Completed | 1 | 18 | Europe | ModraDoc006/r, oral docetaxel formulation | Modra Pharmaceuticals, The Netherlands Cancer Institute | Solid Tumor, Adult | 04/18 | 04/18 | | |
| Completed | 1 | 17 | Europe | ModraDoc006/r, oral docetaxel formulation | Modra Pharmaceuticals | Advanced Solid Tumours | 05/18 | 05/19 | | |
| Completed | 1 | 23 | Europe | ModraDoc006/r, oral docetaxel formulation | Modra Pharmaceuticals, The Netherlands Cancer Institute | Castration-resistant Prostate Cancer | 09/19 | 09/19 | | |
NCT05084456: Oral Docetaxel in Patients With Normal or Impaired Liver Function |
|
|
| Withdrawn | 1 | 0 | Europe | ModraDoc006/r, Oral docetaxel formulation | Modra Pharmaceuticals | Solid Tumor, Adult, Impaired Liver Function | 02/20 | 04/20 | | |